Cardiac remodelling predicts outcome in patients with chronic heart failure. (26th September 2021)

• Record Type: Journal Article
• Authors: Xu, Lingyu; Pagano, Joseph; Chow, Kelvin; Oudit, Gavin Y.; Haykowsky, Mark J.; Mikami, Yoko; Howarth, Andrew G.; White, James A.; Howlett, Jonathan G.; Dyck, Jason R.B.; Anderson, Todd J.; Ezekowitz, Justin A.; Thompson, Richard B.; Paterson, D. Ian
• Is Part Of: ESC heart failure. Volume 8:Number 6(2021)
• Page Start: 5352
• Page End: 5362
• Publication Date: 2021-09-26
• Subjects: Chronic heart failure -- Cardiac remodelling; Heart failure -- Periodicals; 616.129005
• DOI: 10.1002/ehf2.13626
• Languages: English
• ISSNs: 2055-5822

Abstract

Abstract: Aims: Surveillance imaging is often used to detect remodelling, a change in cardiac geometry, and/or function; however, there are limited data in patients with chronic heart failure (HF). We sought to characterize cardiac remodelling in patients with chronic HF and evaluate its association with outcome. Methods and results: A prospective cohort of patients at risk for HF or with chronic HF underwent cardiac magnetic resonance (CMR) at baseline and 1 year. Ventricular function, volumes, mass, left atrial volume, global longitudinal strain, and myocardial scar were measured. The primary outcome was a composite of death or cardiovascular hospitalization up to 5 years from the 1 year scan. Cox regression was used to identify 1 year CMR predictors of outcome after adjusting for baseline risk. A total of 262 patients (median age 68 years, 57% males) including 96 at risk for HF, 97 with HF and preserved ejection fraction, and 69 with HF and reduced ejection fraction were included. In the patients with HF, 55 events were identified during follow‐up. After adjustment for baseline clinical risk, Cox proportion hazard regressions only identified 1 year change in left ventricular (LV) mass index as a CMR predictor of outcome, adjusted hazard ratio 1.21 (1.02, 1.44) per 10% increase, P = 0.031. Cardiac remodelling defined as a 1 year change in LV mass index ≥15% was observed in 35% of patients with HF. Patients with adverse remodelling of LV mass index had more events on Kaplan–Meier analyses compared to those with no remodelling, log‐rank P = 0.004 for overall cohort, P = 0.035 for heart failure with preserved ejection fraction and P = 0.035 for heart failure and reduced ejection fraction. Conclusions: Cardiac remodelling is common during serial CMR assessment of patients with chronic HF. Change in LV mass predicted long‐term outcomes whereas change in left ventricular ejection fraction did not.